Annual EBITDA
-$50.20 M
NaN%
December 1, 2023
Summary
- As of February 8, 2025, CAMP annual EBITDA is -$50.20 million
- During the last 3 years, CAMP annual EBITDA has fallen by -$57.43 million (-794.73%).
- CAMP annual EBITDA is now -181.04% below its all-time high of $61.95 million, reached on February 28, 2018.
Performance
CAMP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$13.10 M
NaN%
September 1, 2024
Summary
- As of February 8, 2025, CAMP quarterly EBITDA is -$13.10 million
- Over the past year, CAMP quarterly EBITDA has dropped by -$16.48 million (-487.63%).
- CAMP quarterly EBITDA is now -153.37% below its all-time high of $24.54 million, reached on August 31, 2017.
Performance
CAMP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$26.14 M
NaN%
September 1, 2024
Summary
- As of February 8, 2025, CAMP TTM EBITDA is -$26.14 million
- Over the past year, CAMP TTM EBITDA has dropped by -$33.80 million (-441.20%).
- CAMP TTM EBITDA is now -134.80% below its all-time high of $75.12 million, reached on May 31, 2018.
Performance
CAMP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CAMP EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.8% | -487.6% | -441.2% |
| 3 y3 years | -794.7% | -2443.3% | -69.2% |
| 5 y5 years | -219.8% | -235.2% | -461.7% |
CAMP EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -794.7% | at low | -487.6% | at low | -441.2% | at low |
| 5 y | 5-year | -219.8% | at low | -317.3% | at low | -284.0% | at low |
| alltime | all time | -181.0% | +44.7% | -153.4% | +79.8% | -134.8% | +76.8% |
CAMP4 Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.10 M(+0.4%) | -$26.14 M(+32.8%) |
| Dec 2023 | -$50.20 M(+13.8%) | -$13.04 M(+9.5%) | -$19.69 M(+363.6%) |
| Sep 2023 | - | -$11.91 M(-452.4%) | -$4.25 M(-155.4%) |
| Aug 2023 | - | $3.38 M(+4.0%) | $7.66 M(+103.4%) |
| May 2023 | - | $3.25 M(-337.9%) | $3.77 M(-186.1%) |
| Feb 2023 | - | -$1.36 M(-156.9%) | -$4.37 M(-65.0%) |
| Dec 2022 | -$44.12 M(+2033.6%) | - | - |
| Nov 2022 | - | $2.40 M(-565.8%) | -$12.51 M(-19.0%) |
| Aug 2022 | - | -$515.00 K(-89.5%) | -$15.45 M(+45.9%) |
| May 2022 | - | -$4.89 M(-48.5%) | -$10.59 M(+411.9%) |
| Feb 2022 | -$2.07 M(-128.6%) | -$9.50 M(+1659.4%) | -$2.07 M(-158.7%) |
| Nov 2021 | - | -$540.00 K(-112.4%) | $3.53 M(-65.1%) |
| Aug 2021 | - | $4.35 M(+19.9%) | $10.10 M(+30.7%) |
| May 2021 | - | $3.63 M(-192.8%) | $7.72 M(+6.9%) |
| Feb 2021 | $7.23 M(-3037.4%) | -$3.91 M(-164.8%) | $7.23 M(-33.4%) |
| Nov 2020 | - | $6.03 M(+205.0%) | $10.86 M(+123.2%) |
| Aug 2020 | - | $1.98 M(-36.8%) | $4.86 M(-41.0%) |
| May 2020 | - | $3.13 M(-1224.8%) | $8.24 M(+17.1%) |
| Feb 2020 | -$246.00 K(-100.6%) | -$278.00 K(-851.4%) | $7.03 M(-50.5%) |
| Nov 2019 | - | $37.00 K(-99.3%) | $14.21 M(-39.8%) |
| Aug 2019 | - | $5.35 M(+178.7%) | $23.60 M(-10.6%) |
| May 2019 | - | $1.92 M(-72.1%) | $26.39 M(-38.1%) |
| Feb 2019 | $41.90 M(-32.4%) | $6.89 M(-26.9%) | $42.64 M(-3.8%) |
| Nov 2018 | - | $9.43 M(+15.9%) | $44.33 M(-24.5%) |
| Aug 2018 | - | $8.14 M(-55.2%) | $58.71 M(-21.8%) |
| May 2018 | - | $18.18 M(+111.8%) | $75.12 M(+21.3%) |
| Feb 2018 | $61.95 M(+146.0%) | $8.58 M(-64.0%) | $61.95 M(+9.2%) |
| Nov 2017 | - | $23.82 M(-2.9%) | $56.71 M(+41.2%) |
| Aug 2017 | - | $24.54 M(+390.4%) | $40.16 M(+55.0%) |
| May 2017 | - | $5.00 M(+49.4%) | $25.92 M(+2.9%) |
| Feb 2017 | $25.18 M(-37.3%) | $3.35 M(-53.9%) | $25.18 M(-17.3%) |
| Nov 2016 | - | $7.27 M(-29.4%) | $30.45 M(-12.6%) |
| Aug 2016 | - | $10.30 M(+141.2%) | $34.84 M(-0.2%) |
| May 2016 | - | $4.27 M(-50.5%) | $34.92 M(-13.0%) |
| Feb 2016 | $40.14 M(+16.4%) | $8.62 M(-26.0%) | $40.14 M(-6.2%) |
| Nov 2015 | - | $11.65 M(+12.3%) | $42.81 M(+7.1%) |
| Aug 2015 | - | $10.38 M(+9.2%) | $39.98 M(+7.6%) |
| May 2015 | - | $9.50 M(-15.8%) | $37.14 M(+7.8%) |
| Feb 2015 | $34.48 M(+30.5%) | $11.28 M(+27.9%) | $34.45 M(+14.8%) |
| Nov 2014 | - | $8.82 M(+17.1%) | $30.01 M(+2.9%) |
| Aug 2014 | - | $7.54 M(+10.7%) | $29.16 M(+2.9%) |
| May 2014 | - | $6.80 M(-0.5%) | $28.32 M(+7.2%) |
| Feb 2014 | $26.42 M(+41.3%) | $6.84 M(-14.2%) | $26.42 M(+10.4%) |
| Nov 2013 | - | $7.97 M(+18.9%) | $23.92 M(+14.0%) |
| Aug 2013 | - | $6.71 M(+36.9%) | $20.99 M(+11.6%) |
| May 2013 | - | $4.90 M(+12.7%) | $18.80 M(+0.6%) |
| Feb 2013 | $18.70 M(+108.1%) | $4.35 M(-13.7%) | $18.70 M(+12.6%) |
| Nov 2012 | - | $5.04 M(+11.4%) | $16.61 M(+19.6%) |
| Aug 2012 | - | $4.52 M(-5.6%) | $13.88 M(+14.0%) |
| May 2012 | - | $4.79 M(+112.7%) | $12.18 M(+35.5%) |
| Feb 2012 | $8.99 M(+1586.1%) | $2.25 M(-2.6%) | $8.99 M(+13.7%) |
| Nov 2011 | - | $2.31 M(-17.9%) | $7.90 M(+24.0%) |
| Aug 2011 | - | $2.82 M(+75.8%) | $6.37 M(+76.6%) |
| May 2011 | - | $1.60 M(+37.1%) | $3.61 M(+578.4%) |
| Feb 2011 | $533.00 K(-106.1%) | $1.17 M(+49.5%) | $532.00 K(-151.4%) |
| Nov 2010 | - | $782.00 K(+1321.8%) | -$1.03 M(-71.6%) |
| Aug 2010 | - | $55.00 K(-103.7%) | -$3.64 M(-48.8%) |
| May 2010 | - | -$1.47 M(+270.4%) | -$7.11 M(-18.8%) |
| Feb 2010 | -$8.76 M(-77.1%) | -$398.00 K(-78.2%) | -$8.76 M(-81.6%) |
| Nov 2009 | - | -$1.83 M(-46.5%) | -$47.53 M(+2.4%) |
| Aug 2009 | - | -$3.42 M(+9.3%) | -$46.41 M(+8.0%) |
| May 2009 | - | -$3.12 M(-92.0%) | -$42.99 M(+12.4%) |
| Feb 2009 | -$38.26 M(-57.9%) | -$39.16 M(+5431.8%) | -$38.26 M(+356.5%) |
| Nov 2008 | - | -$708.00 K(-7966.7%) | -$8.38 M(-88.5%) |
| Aug 2008 | - | $9000.00(-99.4%) | -$72.62 M(-3.1%) |
| May 2008 | - | $1.61 M(-117.3%) | -$74.96 M(-17.5%) |
| Feb 2008 | -$90.83 M(+497.1%) | -$9.29 M(-85.7%) | -$90.83 M(-19.3%) |
| Nov 2007 | - | -$64.95 M(+2692.3%) | -$112.55 M(+162.7%) |
| Aug 2007 | - | -$2.33 M(-83.7%) | -$42.85 M(+21.4%) |
| May 2007 | - | -$14.26 M(-54.0%) | -$35.30 M(-23.9%) |
| Feb 2007 | -$15.21 M(-153.2%) | -$31.01 M(-752.2%) | -$46.39 M(+434.1%) |
| Nov 2006 | - | $4.75 M(-8.9%) | -$8.69 M(+144.5%) |
| Aug 2006 | - | $5.22 M(-120.6%) | -$3.55 M(+148.6%) |
| May 2006 | - | -$25.35 M(-478.8%) | -$1.43 M(-105.0%) |
| Feb 2006 | $28.57 M(+60.0%) | $6.69 M(-32.3%) | $28.57 M(+1.8%) |
| Nov 2005 | - | $9.89 M(+34.7%) | $28.06 M(+26.5%) |
| Aug 2005 | - | $7.34 M(+57.8%) | $22.18 M(+17.7%) |
| May 2005 | - | $4.65 M(-24.7%) | $18.84 M(+5.5%) |
| Feb 2005 | $17.86 M | $6.17 M(+54.1%) | $17.86 M(+13.8%) |
| Nov 2004 | - | $4.01 M(+0.2%) | $15.69 M(-3.7%) |
| Aug 2004 | - | $4.00 M(+8.8%) | $16.29 M(+20.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| May 2004 | - | $3.68 M(-8.2%) | $13.58 M(+44.8%) |
| Feb 2004 | $9.38 M(-21.0%) | $4.01 M(-13.1%) | $9.38 M(+21.7%) |
| Nov 2003 | - | $4.61 M(+257.8%) | $7.71 M(+37.2%) |
| Aug 2003 | - | $1.29 M(-346.0%) | $5.62 M(-30.9%) |
| May 2003 | - | -$524.00 K(-122.4%) | $8.13 M(-31.6%) |
| Feb 2003 | $11.88 M(+24.0%) | $2.34 M(-7.3%) | $11.88 M(-5.3%) |
| Nov 2002 | - | $2.52 M(-33.6%) | $12.54 M(-9.5%) |
| Aug 2002 | - | $3.80 M(+17.8%) | $13.86 M(+19.1%) |
| May 2002 | - | $3.23 M(+7.5%) | $11.63 M(+22.2%) |
| Feb 2002 | $9.58 M(-22.5%) | $3.00 M(-21.8%) | $9.52 M(+6.8%) |
| Nov 2001 | - | $3.84 M(+143.9%) | $8.92 M(+1.0%) |
| Aug 2001 | - | $1.57 M(+41.2%) | $8.83 M(-13.8%) |
| May 2001 | - | $1.11 M(-53.5%) | $10.24 M(-19.1%) |
| Feb 2001 | $12.36 M(+54.4%) | $2.40 M(-36.1%) | $12.65 M(+10.4%) |
| Nov 2000 | - | $3.75 M(+25.8%) | $11.46 M(+4.1%) |
| Aug 2000 | - | $2.98 M(-15.4%) | $11.01 M(+5.6%) |
| May 2000 | - | $3.53 M(+192.6%) | $10.43 M(+30.4%) |
| Feb 2000 | $8.01 M(+129.6%) | $1.21 M(-63.5%) | $8.00 M(-23.7%) |
| Nov 1999 | - | $3.30 M(+37.5%) | $10.48 M(+36.5%) |
| Aug 1999 | - | $2.40 M(+119.6%) | $7.68 M(+71.4%) |
| May 1999 | - | $1.09 M(-70.3%) | $4.48 M(+28.5%) |
| Feb 1999 | $3.49 M(-797.2%) | $3.69 M(+637.2%) | $3.49 M(-239.4%) |
| Nov 1998 | - | $500.00 K(-162.5%) | -$2.50 M(-28.6%) |
| Aug 1998 | - | -$800.00 K(-900.0%) | -$3.50 M(+133.3%) |
| May 1998 | - | $100.00 K(-104.3%) | -$1.50 M(+150.0%) |
| Feb 1998 | -$500.00 K(-118.5%) | -$2.30 M(+360.0%) | -$600.00 K(-400.0%) |
| Nov 1997 | - | -$500.00 K(-141.7%) | $200.00 K(-88.2%) |
| Aug 1997 | - | $1.20 M(+20.0%) | $1.70 M(+88.9%) |
| May 1997 | - | $1.00 M(-166.7%) | $900.00 K(-70.0%) |
| Feb 1997 | $2.70 M(-73.5%) | -$1.50 M(-250.0%) | $3.00 M(-61.0%) |
| Nov 1996 | - | $1.00 M(+150.0%) | $7.70 M(-18.1%) |
| Aug 1996 | - | $400.00 K(-87.1%) | $9.40 M(-17.5%) |
| May 1996 | - | $3.10 M(-3.1%) | $11.40 M(+12.9%) |
| Feb 1996 | $10.20 M(+61.9%) | $3.20 M(+18.5%) | $10.10 M(+14.8%) |
| Nov 1995 | - | $2.70 M(+12.5%) | $8.80 M(+11.4%) |
| Aug 1995 | - | $2.40 M(+33.3%) | $7.90 M(+12.9%) |
| May 1995 | - | $1.80 M(-5.3%) | $7.00 M(+18.6%) |
| Feb 1995 | $6.30 M(+53.7%) | $1.90 M(+5.6%) | $5.90 M(+31.1%) |
| Nov 1994 | - | $1.80 M(+20.0%) | $4.50 M(+9.8%) |
| Aug 1994 | - | $1.50 M(+114.3%) | $4.10 M(+5.1%) |
| May 1994 | - | $700.00 K(+40.0%) | $3.90 M(-66.9%) |
| Feb 1994 | $4.10 M(-21.2%) | $500.00 K(-64.3%) | $11.80 M(-7.1%) |
| Nov 1993 | - | $1.40 M(+7.7%) | $12.70 M(+3.3%) |
| Aug 1993 | - | $1.30 M(-84.9%) | $12.30 M(-1.6%) |
| May 1993 | - | $8.60 M(+514.3%) | $12.50 M(+135.8%) |
| Feb 1993 | $5.20 M(+100.0%) | $1.40 M(+40.0%) | $5.30 M(-162.4%) |
| Nov 1992 | - | $1.00 M(-33.3%) | -$8.50 M(+107.3%) |
| Aug 1992 | - | $1.50 M(+7.1%) | -$4.10 M(-18.0%) |
| May 1992 | - | $1.40 M(-111.3%) | -$5.00 M(-18.0%) |
| Feb 1992 | $2.60 M(+2500.0%) | -$12.40 M(-329.6%) | -$6.10 M(-196.8%) |
| Nov 1991 | - | $5.40 M(+800.0%) | $6.30 M(+1160.0%) |
| Aug 1991 | - | $600.00 K(+100.0%) | $500.00 K(+150.0%) |
| May 1991 | - | $300.00 K(>+9900.0%) | $200.00 K(+100.0%) |
| Feb 1991 | $100.00 K(-85.7%) | $0.00(-100.0%) | $100.00 K(-101.3%) |
| Nov 1990 | - | -$400.00 K(-233.3%) | -$8.00 M(+77.8%) |
| Aug 1990 | - | $300.00 K(+50.0%) | -$4.50 M(+136.8%) |
| May 1990 | - | $200.00 K(-102.5%) | -$1.90 M(-733.3%) |
| Feb 1990 | $700.00 K(+250.0%) | -$8.10 M(-361.3%) | $300.00 K(-80.0%) |
| Nov 1989 | - | $3.10 M(+6.9%) | $1.50 M(+150.0%) |
| Aug 1989 | - | $2.90 M(+20.8%) | $600.00 K(-400.0%) |
| May 1989 | - | $2.40 M(-134.8%) | -$200.00 K(-33.3%) |
| Feb 1989 | $200.00 K(-80.0%) | -$6.90 M(-413.6%) | -$300.00 K(-120.0%) |
| Nov 1988 | - | $2.20 M(+4.8%) | $1.50 M(0.0%) |
| Aug 1988 | - | $2.10 M(-8.7%) | $1.50 M(+25.0%) |
| May 1988 | - | $2.30 M(-145.1%) | $1.20 M(+71.4%) |
| Feb 1988 | $1.00 M(-23.1%) | -$5.10 M(-331.8%) | $700.00 K(+16.7%) |
| Nov 1987 | - | $2.20 M(+22.2%) | $600.00 K(+200.0%) |
| Aug 1987 | - | $1.80 M(0.0%) | $200.00 K(-50.0%) |
| May 1987 | - | $1.80 M(-134.6%) | $400.00 K(-55.6%) |
| Feb 1987 | $1.30 M(-128.3%) | -$5.20 M(-388.9%) | $900.00 K(-107.9%) |
| Nov 1986 | - | $1.80 M(-10.0%) | -$11.40 M(+25.3%) |
| Aug 1986 | - | $2.00 M(-13.0%) | -$9.10 M(+31.9%) |
| May 1986 | - | $2.30 M(-113.1%) | -$6.90 M(+9.5%) |
| Feb 1986 | -$4.60 M(+475.0%) | -$17.50 M(-526.8%) | -$6.30 M(+5.0%) |
| Nov 1985 | - | $4.10 M(-2.4%) | -$6.00 M(+13.2%) |
| Aug 1985 | - | $4.20 M(+44.8%) | -$5.30 M(+10.4%) |
| May 1985 | - | $2.90 M(-116.9%) | -$4.80 M(+200.0%) |
| Feb 1985 | -$800.00 K(-116.7%) | -$17.20 M(-458.3%) | -$1.60 M(-110.3%) |
| Nov 1984 | - | $4.80 M(+2.1%) | $15.60 M(+44.4%) |
| Aug 1984 | - | $4.70 M(-23.0%) | $10.80 M(+77.0%) |
| May 1984 | - | $6.10 M | $6.10 M |
| Feb 1984 | $4.80 M | - | - |
FAQ
- What is CAMP4 Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for CAMP4 Therapeutics?
- What is CAMP4 Therapeutics annual EBITDA year-on-year change?
- What is CAMP4 Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for CAMP4 Therapeutics?
- What is CAMP4 Therapeutics quarterly EBITDA year-on-year change?
- What is CAMP4 Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for CAMP4 Therapeutics?
- What is CAMP4 Therapeutics TTM EBITDA year-on-year change?
What is CAMP4 Therapeutics annual EBITDA?
The current annual EBITDA of CAMP is -$50.20 M
What is the all time high annual EBITDA for CAMP4 Therapeutics?
CAMP4 Therapeutics all-time high annual EBITDA is $61.95 M
What is CAMP4 Therapeutics annual EBITDA year-on-year change?
Over the past year, CAMP annual EBITDA has changed by -$6.08 M (-13.78%)
What is CAMP4 Therapeutics quarterly EBITDA?
The current quarterly EBITDA of CAMP is -$13.10 M
What is the all time high quarterly EBITDA for CAMP4 Therapeutics?
CAMP4 Therapeutics all-time high quarterly EBITDA is $24.54 M
What is CAMP4 Therapeutics quarterly EBITDA year-on-year change?
Over the past year, CAMP quarterly EBITDA has changed by -$16.48 M (-487.63%)
What is CAMP4 Therapeutics TTM EBITDA?
The current TTM EBITDA of CAMP is -$26.14 M
What is the all time high TTM EBITDA for CAMP4 Therapeutics?
CAMP4 Therapeutics all-time high TTM EBITDA is $75.12 M
What is CAMP4 Therapeutics TTM EBITDA year-on-year change?
Over the past year, CAMP TTM EBITDA has changed by -$33.80 M (-441.20%)